日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
10/04/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | 刘殿波 | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Nelumbo Investments Limited | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Life Sciences Group Ltd | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | LuYe Pharmaceutical International Co., Ltd. | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Pharma Holdings Ltd. | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Pharma Holdings Ltd. | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Shorea LBG | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | UBS Group AG | 1213(L) | -16,160,500(L) | 472,981,078(L) 342,159,864(S) | 12.57 9.10 | |
10/04/2024 | LuYe Pharmaceutical International Co., Ltd. | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Nelumbo Investments Limited | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Shorea LBG | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Ginkgo (PTC) Limited | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
09/04/2024 | UBS Group AG | 1104(L) | +3,392,862(L) | 489,143,078(L) 349,703,364(S) | 13.00 9.30 | |
04/04/2024 | UBS Group AG | 1205(L) | -6,316,500(L) | 483,718,078(L) 342,664,864(S) | 12.86 9.11 | |
02/04/2024 | UBS Group AG | 1104(L) | +6,316,500(L) | 491,522,578(L) 349,703,364(S) | 13.07 9.30 | |
29/03/2024 | UBS Group AG | 1205(L) | -6,316,500(L) | 483,711,216(L) 347,236,002(S) | 12.86 9.23 | |
27/03/2024 | UBS Group AG | 1305(L) | 5,449,187(L) | 491,095,828(L) 351,208,864(S) | 13.06 9.34 | |
26/03/2024 | UBS Group AG | 1104(L) | +9,709,362(L) | 496,904,342(L) 358,247,364(S) | 13.21 9.52 | |
25/03/2024 | UBS Group AG | 1205(L) | -4,135,362(L) | 485,422,730(L) 347,236,002(S) | 12.90 9.23 | |
22/03/2024 | UBS Group AG | 1104(L) | +742,500(L) | 489,561,592(L) 351,951,364(S) | 13.01 9.36 | |
20/03/2024 | UBS Group AG | 1205(L) | -9,709,362(L) | 482,119,230(L) 347,978,502(S) | 12.82 9.25 | |
19/03/2024 | UBS Group AG | 1104(L) | +6,316,500(L) | 494,449,092(L) 358,247,364(S) | 13.14 9.52 | |
18/03/2024 | UBS Group AG | 1205(L) | -6,316,500(L) | 488,018,092(L) 351,951,364(S) | 12.97 9.36 | |
15/03/2024 | UBS Group AG | 1104(L) | +6,316,500(L) | 490,453,230(L) 354,274,502(S) | 13.04 9.42 | |
27/02/2024 | UBS Group AG | 1306(L) | 37,375,424(L) | 485,895,534(L) 357,702,573(S) | 12.92 9.51 | |
23/02/2024 | UBS Group AG | 1306(L) | 21,132,736(L) | 471,710,529(L) 342,033,436(S) | 12.54 9.09 | |
14/02/2024 | UBS Group AG | 1305(L) | 21,132,736(L) | 464,858,030(L) 344,326,161(S) | 12.36 9.15 | |
13/02/2024 | UBS Group AG | 1306(L) | 35,962,431(L) | 468,373,392(L) 348,151,023(S) | 12.45 9.26 | |
09/02/2024 | UBS Group AG | 1305(L) | 35,962,431(L) | 468,530,892(L) 348,308,523(S) | 12.46 9.26 | |
08/02/2024 | UBS Group AG | 1305(L) | 7,459,495(L) | 468,300,892(L) 348,308,523(S) | 12.45 9.26 | |
01/02/2024 | UBS Group AG | 1313(L) | 1,000,000(L) | 476,910,953(L) 354,606,318(S) | 12.68 9.43 | |
24/01/2024 | UBS Group AG | 12043(L) | -19,559,356(L) | 486,066,694(L) 355,230,503(S) | 12.92 9.44 | |
16/01/2024 | UBS Group AG | 1201(L) | -880,500(L) | HKD3.302(L) | 525,831,028(L) 352,215,654(S) | 13.98 9.36 |
12/01/2024 | Shorea LBG | 1101(L) | +2,000,000(L) | HKD3.311(L) | 1,259,196,703(L) 200,861,950(S) | 33.47 5.34 |
12/01/2024 | 刘殿波 | 1101(L) | +2,000,000(L) | HKD3.311(L) | 1,259,196,703(L) 200,861,950(S) | 33.47 5.34 |
12/01/2024 | Luye Pharma Holdings Ltd. | 1101(L) | +2,000,000(L) | HKD3.311(L) | 1,259,196,703(L) 200,861,950(S) | 33.47 5.34 |
12/01/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1101(L) | +2,000,000(L) | HKD3.311(L) | 1,259,196,703(L) 200,861,950(S) | 33.47 5.34 |
12/01/2024 | Luye Life Sciences Group Ltd | 1101(L) | +2,000,000(L) | HKD3.311(L) | 1,259,196,703(L) 200,861,950(S) | 33.47 5.34 |
1 2 3 4 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 04/09/2024 10:04 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |